LTIP461A - Non-stinging vaccine composition - Google Patents
Non-stinging vaccine compositionInfo
- Publication number
- LTIP461A LTIP461A LTIP461A LTIP461A LTIP461A LT IP461 A LTIP461 A LT IP461A LT IP461 A LTIP461 A LT IP461A LT IP461 A LTIP461 A LT IP461A LT IP461 A LTIP461 A LT IP461A
- Authority
- LT
- Lithuania
- Prior art keywords
- stinging
- vaccine composition
- vaccine
- composition
- stinging vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0015—Combination vaccines based on measles-mumps-rubella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/165—Mumps or measles virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/20—Rubella virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36211—Rubivirus, e.g. rubella virus
- C12N2770/36234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70191891A | 1991-05-17 | 1991-05-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LTIP461A true LTIP461A (en) | 1994-10-25 |
Family
ID=24819190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTIP461A LTIP461A (en) | 1991-05-17 | 1993-03-30 | Non-stinging vaccine composition |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0514208A1 (en) |
| JP (1) | JPH05221876A (en) |
| KR (1) | KR920021163A (en) |
| CN (1) | CN1068268A (en) |
| AU (1) | AU1633092A (en) |
| CA (1) | CA2068742A1 (en) |
| IE (1) | IE921577A1 (en) |
| IL (1) | IL101890A0 (en) |
| LT (1) | LTIP461A (en) |
| MX (1) | MX9202293A (en) |
| WO (1) | WO1992020375A1 (en) |
| ZA (1) | ZA923548B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2657801C1 (en) * | 2016-12-22 | 2018-06-15 | Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации (ФГУП "НПО "Микроген" Минздрава России) | Combined vaccine for the immunoprophylaxis of measles, contagious parotitis and rubella |
| TR202016134A2 (en) * | 2020-10-09 | 2022-04-21 | Miracle Labs Ilac Sanayi Ve Ticaret Anonim Sirketi | COVID-19 VIRUS VACCINE |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT71926B (en) * | 1979-10-29 | 1982-03-31 | Merck & Co Inc | Process for preparing a liquid vaccine comprising a stabilizer |
| FR2505657A1 (en) * | 1981-05-13 | 1982-11-19 | Pasteur Institut | IMPROVEMENTS IN LIVE STABILIZING AGENTS FOR THE PREPARATION OF VACCINES, AND STABILIZED VACCINES CONTAINING SAID STABILIZING AGENTS |
| JPS6314729A (en) * | 1986-06-30 | 1988-01-21 | スミスクライン・バイオロジカルス・ソシエテ・アノニム | Improved stabilizer for live vaccine, manufacture and vaccine containing same |
-
1992
- 1992-05-15 WO PCT/US1992/004097 patent/WO1992020375A1/en not_active Application Discontinuation
- 1992-05-15 CA CA002068742A patent/CA2068742A1/en not_active Abandoned
- 1992-05-15 MX MX9202293A patent/MX9202293A/en unknown
- 1992-05-15 IL IL101890A patent/IL101890A0/en unknown
- 1992-05-15 ZA ZA923548A patent/ZA923548B/en unknown
- 1992-05-15 EP EP92304433A patent/EP0514208A1/en not_active Withdrawn
- 1992-05-15 AU AU16330/92A patent/AU1633092A/en not_active Abandoned
- 1992-05-16 CN CN92104548A patent/CN1068268A/en active Pending
- 1992-05-18 JP JP4168190A patent/JPH05221876A/en active Pending
- 1992-05-18 KR KR1019920008517A patent/KR920021163A/en not_active Application Discontinuation
- 1992-07-01 IE IE157792A patent/IE921577A1/en not_active Application Discontinuation
-
1993
- 1993-03-30 LT LTIP461A patent/LTIP461A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX9202293A (en) | 1992-11-01 |
| WO1992020375A1 (en) | 1992-11-26 |
| AU1633092A (en) | 1992-11-19 |
| KR920021163A (en) | 1992-12-18 |
| IE921577A1 (en) | 1992-11-18 |
| IL101890A0 (en) | 1992-12-30 |
| JPH05221876A (en) | 1993-08-31 |
| CA2068742A1 (en) | 1992-11-18 |
| ZA923548B (en) | 1992-12-30 |
| CN1068268A (en) | 1993-01-27 |
| EP0514208A1 (en) | 1992-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG49909A1 (en) | Vaccine composition containing adjuvants | |
| IL105161A0 (en) | Vaccine compositions | |
| IL101290A0 (en) | Vaccine formulations | |
| GB8924438D0 (en) | Vaccine composition | |
| EP0454735A4 (en) | Vaccine composition | |
| AP9200356A0 (en) | Pharmaceutical composition | |
| GB9108080D0 (en) | Pharmaceutical composition | |
| PL313979A1 (en) | Vaccine composition | |
| AP9000165A0 (en) | Vaccine composition | |
| IL101890A0 (en) | Non-stinging vaccine composition | |
| GB2252497B (en) | Pharmaceutical composition | |
| IE900354L (en) | Vaccine composition | |
| GB9111477D0 (en) | Pharmaceutical composition | |
| GB9122766D0 (en) | Medicament composition | |
| GB9122768D0 (en) | Medicament composition | |
| GB9109973D0 (en) | Therapeutic compositions | |
| IL100149A0 (en) | Dental composition | |
| ZA90766B (en) | Vaccine composition | |
| GB9111210D0 (en) | Pharmaceutical composition | |
| GB9108129D0 (en) | Pharmaceutical composition | |
| GB9108410D0 (en) | Pharmaceutical composition | |
| GB9101675D0 (en) | Pharmaceutical composition | |
| AP9200454A0 (en) | Pharmaceutical composition | |
| GB9114149D0 (en) | Pharmaceutical composition | |
| GB9116066D0 (en) | Pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HK9A | Rectifications: patent applications |
Free format text: A61K 39/295, A61K39/12, 19960616, |